Federal Regulations

After Congress passes a law, federal agencies write the detailed rules that make it real. Each rulemaking project gets a — and while a rule is proposed, anyone can comment on it.

13,034

rulemaking dockets

4,738

open for public comment

You can weigh in on these right now

Showing 30 of 13,034 dockets

Nonrulemaking

FDA

FDA-2026-H-2159

DAB Civil Money Penalty; Team Dreamers LLC, d/b/a Vape N Smoke; CLOSED 04/10/2026

1 docNo comments

Nonrulemaking

FDA

FDA-2026-H-0292

DAB Civil Money Penalty; Bradley P. Edwards and Charles Edwards Jr. d/b/a Edwards Grocery; CLOSED 04/10/2026

1 docNo comments

Nonrulemaking

FDA

FDA-2026-H-2291

DAB Civil Money Penalty; MK Stores LLC, d/b/a Marathon / Snak Atak 33; CLOSED 04/10/2026

1 docNo comments

Nonrulemaking

FDA

FDA-2026-H-3156

DAB Civil Money Penalty; T & B Enterprises of Rockland, Inc. d/b/a T & B's Grocery & Restaurant; CLOSED 04/10/2026

1 docNo comments

Nonrulemaking

FDA

FDA-2026-H-2907

DAB Civil Money Penalty; Marywhite Enterprises Inc. d/b/a Marathon; CLOSED 04/10/2026

1 docNo comments

Nonrulemaking

FDA

FDA-2026-H-2714

DAB Civil Money Penalty; Hy-Vee, Inc. d/b/a Hy-Vee Fast & Fresh 5; CLOSED 04/10/2026

1 docNo comments

Nonrulemaking

FDA

FDA-2026-H-2609

DAB Civil Money Penalty; Family Dollar Stores of New Jersey, LLC d/b/a Family Dollar 6965; CLOSED 04/10/2026

1 docNo comments

Nonrulemaking

FDA

FDA-1995-N-0225

Topical Antimicrobial Drug Products for OTC Human Use

9 docs1 comment

Nonrulemaking

USDA

USDA-2026-0034

USDA Seeks Public Input on Future of Farm Data, Research and Statistics

2 docs244 comments

Nonrulemaking

FDA

FDA-1995-P-0035

Use URAA to Determine Approval eff date of ANDA's

2 docs9 comments

Nonrulemaking

BOEM

BOEM-2025-0681

Interior agency to study environmental impacts of proposed offshore oil and gas lease sales off California

1 doc933 comments

Nonrulemaking

FDA

FDA-1995-P-0024

Refuse to Approve Any NDA for RU 486 Used as Abortifacient

1 docNo comments

Nonrulemaking

FDA

Open for Comments

FDA-1995-D-0288

Changes to Be Reported for Product & Establishment License Application; Guidance

39 docs16 comments

Comments due Mar 23, 2018

Nonrulemaking

FDA

FDA-2026-E-3826

Patent Term Extension Application for VOYXACT® (sibeprenlimab-szsi), Patent No. 10,385,123

2 docsNo comments

Nonrulemaking

FDA

FDA-1995-P-0373

Metered Dose N-acetylcysteine lysinate for Human Use via Oral Inhalation

15 docsNo comments

Nonrulemaking

FDA

Open for Comments

FDA-2026-N-0496

FDA Seeks Public Comment on Recordkeeping Rules for Medicated Animal Feed Makers

1 doc1 comment

Comments due Apr 28, 2026

Nonrulemaking

FDA

FDA-2026-E-3828

Patent Term Extension Application for YARTEMLEA® (narsoplimab-wuug), Patent No. 9,011,860

2 docsNo comments

Nonrulemaking

FDA

FDA-2026-E-3824

Patent Term Extension Application for NUZOLVENCE® (zoliflodacin), Patent No. 9,187,495

2 docsNo comments

Nonrulemaking

FDA

FDA-2026-E-3822

Patent Term Extension Application for NEREUS® (tradipitant), Patent No. 12,318,375

2 docsNo comments

Nonrulemaking

FDA

FDA-2026-E-3821

Patent Term Extension Application for NEREUS® (tradipitant), Patent No. 11,324,735

2 docsNo comments

Nonrulemaking

FDA

FDA-2026-E-3820

Patent Term Extension Application for NEREUS® (tradipitant), Patent No. 10,821,099

2 docsNo comments

Nonrulemaking

FDA

FDA-2026-E-3819

Patent Term Extension Application for NEREUS® (tradipitant), Patent No. 10,772,880

2 docsNo comments

Nonrulemaking

FDA

FDA-2026-E-3818

Patent Term Extension Application for MYQORZO™ (aficamten), Patent No. 10,836,755

2 docsNo comments

Nonrulemaking

FDA

FDA-2026-E-3817

Patent Term Extension Application for LEROCHOL® (lerodalcibep-liga), Patent No. 10,738,102

2 docsNo comments

Nonrulemaking

FDA

FDA-2026-E-3816

Patent Term Extension Application for EXDENSUR® (depemokimab-ulaa), Patent No. 10,787,509

2 docsNo comments

Nonrulemaking

FDA

FDA-2026-E-3815

Patent Term Extension Application for CARDAMYST™ (etripamil).Patent No. 10,117,848

3 docsNo comments

Nonrulemaking

FDA

FDA-2026-E-3814

Patent Term Extension Application for CARDAMYST™ (etripamil).Patent No. 10,010,523

3 docsNo comments

Nonrulemaking

FDA

FDA-2026-E-3813

Patent Term Extension Application for CARDAMYST™ (etripamil). Patent No. 10,010,522

3 docsNo comments

Nonrulemaking

FDA

FDA-2026-E-3812

Patent Term Extension Application for CARDAMYST™ (etripamil), Patent No. 9,463,179

3 docsNo comments

Nonrulemaking

FDA

FDA-2026-E-3811

Patent Term Extension Application for CARDAMYST™ (etripamil), Patent No. 9,227,918

3 docsNo comments